In an effort to maximize the earnings potential of its plaque psoriasis cream, Danish dermatology biotech MC2 Therapeutics ...

From Novo Nordisk to UnitedHealth, onetime chief executives are returning to guide their former organizations in times of ...

This transition reflects a planned and strategic evolution of MC2 Therapeutics, aligned with the company’s focus on commercial expansion.

As previously announced, Kathryn Leaf has assumed the role of Chief Executive Officer, while Jeff Miller is now Chief Investment Officer. Kathryn and Jeff both joined Pantheon in 2008, and most ...